KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $94.0 million.

  • Cme Group's Capital Expenditures fell 38.26% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.2 million, marking a year-over-year decrease of 12.87%. This contributed to the annual value of $94.0 million for FY2024, which is 23.04% up from last year.
  • Cme Group's Capital Expenditures amounted to $94.0 million in FY2024, which was up 23.04% from $76.4 million recorded in FY2023.
  • In the past 5 years, Cme Group's Capital Expenditures ranged from a high of $197.5 million in FY2020 and a low of $76.4 million during FY2023.
  • In the last 3 years, Cme Group's Capital Expenditures had a median value of $89.7 million in 2022 and averaged $86.7 million.
  • As far as peak fluctuations go, Cme Group's Capital Expenditures tumbled by 35.59% in 2021, and later increased by 23.04% in 2024.
  • Yearly analysis of 5 years shows Cme Group's Capital Expenditures stood at $197.5 million in 2020, then tumbled by 35.59% to $127.2 million in 2021, then declined by 29.48% to $89.7 million in 2022, then declined by 14.83% to $76.4 million in 2023, then grew by 23.04% to $94.0 million in 2024.